Cargando…
IgM responses following SARS-CoV-2 vaccination: insights into protective and pre-existing immunity
Autor principal: | Fraussen, Judith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897598/ https://www.ncbi.nlm.nih.gov/pubmed/35259573 http://dx.doi.org/10.1016/j.ebiom.2022.103922 |
Ejemplares similares
-
Human IgM and IgG Responses to an Inactivated SARS-CoV-2 Vaccine
por: Banga Ndzouboukou, Jo-Lewis, et al.
Publicado: (2021) -
SARS-COV-2 IgG and IgM Antibodies in Cancer Patients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021) -
Rubella IgM epidemiology in the pre-rubella vaccination era in Uganda
por: Bagenda, Fred, et al.
Publicado: (2020) -
IgM and IgG Immunoreactivity of SARS-CoV-2 Recombinant M Protein
por: Lopandić, Zorana, et al.
Publicado: (2021) -
Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2
por: Klingler, Jéromine, et al.
Publicado: (2020)